Abstract
Multiple sclerosis (MS) is an autoimmune disease characterized by demyelination, axonal loss and neurodegeneration. Treatment for patients with MS is carried out using immunomodulators and immunosuppressants, seeking to reduce the risk of new outbreaks and the progression of neurological disability. The Experimental Autoimmune Encephalomyelitis (EAE) model is used to study the mechanisms …